- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Vidar unveils mammography digitizer
Vidar Systems of Herndon, VA, launched a new film digitizer at last month’s Society of Breast Imaging meeting in Boston. Vidar’s MammographyPro is designed for digitizing mammography films, and can enable users to perform such
Vidar Systems of Herndon, VA, launched a new film digitizer at last months Society of Breast Imaging meeting in Boston. Vidars MammographyPro is designed for digitizing mammography films, and can enable users to perform such applications as remote primary diagnosis and computer assisted diagnosis. MammographyPro uses Vidars High Definition CCD (HD-CCD) technology, and features a spot size of 31 microns, as well as an optical density range of zero to 3.65. MammographyPro will be available this summer, and will list at approximately $20,000.
In other Vidar news, the company announced May 13 that it has established a supplier relationship with StorComm of Jacksonville, FL. Under the terms of the agreement, Vidar will supply StorComm with its HD-CCD digitizers DiagnosticPro and TeleRadPro for StorComms Clinical Image Management Systems. Also in May, Vidar signed an agreement with Meta Solutions of Linthicum, MD, in which Meta will include Vidar products in its teleradiology and PACS offerings.
© 1999 Miller Freeman, Inc.All rights reserved.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
